ADVISORY, Nov. 16, 2016 (GLOBE NEWSWIRE) --
What:
Catabasis Pharmaceuticals, Inc. (Nasdaq:CATB), a clinical-stage biopharmaceutical company, will visit the Nasdaq
MarketSite in Times Square.
In honor of the occasion, Jill C. Milne, Co-Founder and CEO, will ring the Closing Bell.
Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
When:
Thursday, November 17, 2016 – 3:45 p.m. to 4:00 p.m. ET
Catabasis Contact:
Andrea Matthews
(617) 349-1971
amatthews@catabasis.com
Nasdaq MarketSite:
Emily Pan
(646) 441-5120
emily.pan@nasdaq.com
Feed Information:
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK
Social Media:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please
visit our Facebook page:
http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our Instagram page:
http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our YouTube page:
http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter page:
http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our Tumblr page:
http://nasdaq.tumblr.com/
Webcast:
A live stream of the Nasdaq Closing Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos:
To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your
choice.
About Catabasis
At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families.
Our SMART (Safely Metabolized And Rationally Targeted) linker drug discovery platform enables us to engineer molecules that
simultaneously modulate multiple targets in a disease. We are applying our SMART linker platform to build an internal pipeline of
product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates. For more information
on the Company's drug discovery platform and pipeline of drug candidates, please visit www.catabasis.com.
About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public
company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and
execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70
marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed
companies with a market value of $10 trillion and approximately 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com
-NDAQA-
